Spotlight On... Unilife CEO resigns from drug delivery device company amid post-Amgen deal reorg; Greatbatch completes publicly traded neurostim spinoff; HeartWare adds investor to board; and more...

On the heels of a much-needed alliance with Amgen ($AMGN) which gave it a cash lifeline, drug delivery device specialist Unilife ($UNIS) has entered restructure mode. The struggling York, PA, company announced that its CEO, Alan Shortall, and COO, Dr. Ramin Mojdeh, have resigned. Executive search firm Heidrick & Struggles will be searching for a permanent CEO, while senior vice president and general counsel John Ryan takes the helm as interim CEO. He will be helped by a new executive leadership team. In addition, the company now has two business units: Wearable and Auto Injectors and Prefilled Syringes. More

@FierceMedDev: San Diego startup raises $25M+ for prostate cancer genomics just after launch of latest test. Article | Follow @FierceMedDev

@EmilyWFierce: $WOOF charges ahead with $344M deal for vet hospital chain CAPNA. FierceAnimalHealth story | Follow @EmilyWFierce

> The FDA has cleared the instruments and reloads for the da Vinci Xi EndoWrist Stapler 30 from Intuitive Surgical ($ISRG). More

> Miniaturized circulatory support player HeartWare ($HTWR) has added Chadwick Cornell, managing director at private equity firm Goldner Hawn Johnson & Morrison. He was previously the VP of Corporate Development at Medtronic ($MDT). The move comes as the company has been working to appease activist investors. More

> Greatbatch ($GB) has completed its spinout of neurostimulation company Nuvectra ($NVTR). More

Biotech News

@FierceBiotech: Google backs Cambridge epigenetics spinoff in a $21M round. Article | Follow @FierceBiotech

@JohnCFierce: NEJM correction acknowledges CAR developers Dario Campana and Chihaya Imai. More | Follow @JohnCFierce

> Biotech unicorn Stemcentrx is reportedly up for a multibillion-dollar sale. Article

> Battered PTC hits reset on its DMD ambitions in Canada. More

> GW Pharma soars as its cannabis-derived drug aces Phase III. Report

Pharma News

@FiercePharma: ICYMI: VA to stop restricting hep C drugs, offering them to all infected veterans. More | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Vertex, committed to continuous manufacturing, has Hovione build plant to complement the one it already has. Article | Follow @EricPFierce

@CarlyHFierce: Teva speeds toward Allergan deal close with EU thumbs up. Report | Follow @CarlyHFierce

> Pfizer wins stay from Indian court after regulator bans popular cough syrups. News

> Hospitals join drug price-fighting battalion with plans to crack down on spending. More

Animal Health News

> Figo brings home $4M to spur development of mobile tech for pet owners. Story

> Ceva makes strides toward animal health dominance with strong 2015 sales. Article

> VCA charges ahead with $344M deal for vet hospital chain CAPNA. Report

> Head of FDA's Veterinary Medicine program moves to greener pastures. Item

> Zoetis and Merial ink pact to market drugs and vaccines for dairy cattle in India. News

Biotech IT News

> Medidata stutters in attempt to recoup $4.8M in wire fraud losses. Item

> Ambry starts genetic data dump with release of 10,000 exome cancer repository. More

> Genstar flips eClinical player ERT to Nordic Capital for 8-times return. Report

> Boehringer signs up to use Genedata biologics R&D data platform. Story

> PatientsLikeMe taps AstraZeneca, Roche for cash to fuse outcomes, clinical and molecular data. Article

Pharma Marketing News

> Pfizer widens Xalkori's reach with another targeted lung cancer approval. Report

> Novo's combo med Xultophy set for blockbuster-plus sales, analyst figures. More

> India reclears Roche's Avastin for off-label eye sales. Item

> Merck's Keytruda held back by docs who don't want to wait for diagnostics. Story

> Sarilumab's new Humira-beating data poses another threat to AbbVie's megablockbuster sales. Article